Search Results - "Tomberli, Alessia"

Doctor-patient care relationship in genetic cardiomyopathies: An exploratory study on clinical consultations by Fioretti, Chiara, Magni, Elisa, Barlocco, Fausto, Tomberli, Alessia, Baldini, Katia, Ingles, Jodie, Smorti, Andrea, Olivotto, Iacopo

“…Background The present study aims to explore the setting of consultation and communication between physicians and patients affected by genetic…”
Get full text

Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis by Smorti, Martina, Ponti, Lucia, Soffio, Francesco, Argirò, Alessia, Perfetto, Federico, Zampieri, Mattia, Mazzoni, Carlotta, Tomberli, Alessia, Allinovi, Marco, Di Mario, Carlo, Olivotto, Iacopo, Cappelli, Francesco

“…Patients with ATTR cardiac amyloidosis (ATTR-CA) face rare disease that could negatively influence psychological well-being with consequences on the course of…”
Get full text

Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not by Argirò, Alessia, Del Franco, Annamaria, Mazzoni, Carlotta, Allinovi, Marco, Tomberli, Alessia, Tarquini, Roberto, Di Mario, Carlo, Perfetto, Federico, Cappelli, Francesco, Zampieri, Mattia

“…Cardiac amyloidosis (CA), caused by the deposition of insoluble amyloid fibrils, impairs different cardiac structures, altering not only left ventricle (LV)…”
Get full text

Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome by De Gregorio, Maria Grazia, Girolami, Francesca, Tomberli, Benedetta, Rossi, Guendalina, Tomberli, Alessia, Baldini, Katia, Olivotto, Iacopo

“…In a 37-year-old cardiac arrest survivor with autosomal dominant Carvajal syndrome and arrhythmogenic cardiomyopathy, a desmoplakin mutation was identified…”
Get full text

The evolving paradigm and current perception of hypertrophic cardiomyopathy: Implications for management by Del Franco, Annamaria, Menale, Silvia, Chiti, Chiara, Biagioni, Giulia, Tomberli, Alessia, Zampieri, Mattia, Olivotto, Iacopo

“…Recent evidence from imaging and genetic screening studies has clearly shown that hypertrophic cardiomyopathy (HCM) is more common than initially perceived,…”
Get full text

Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center by Mazzarotto, Francesco, Girolami, Francesca, Boschi, Beatrice, Barlocco, Fausto, Tomberli, Alessia, Baldini, Katia, Coppini, Raffaele, Tanini, Ilaria, Bardi, Sara, Contini, Elisa, Cecchi, Franco, Pelo, Elisabetta, Cook, Stuart A., Cerbai, Elisabetta, Poggesi, Corrado, Torricelli, Francesca, Walsh, Roddy, Olivotto, Iacopo

“…Purpose Genetic testing in hypertrophic cardiomyopathy (HCM) has long relied on Sanger sequencing of sarcomeric genes. The advent of next-generation sequencing…”
Get full text

Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis by Zampieri, Mattia, Argirò, Alessia, Allinovi, Marco, Tassetti, Luigi, Zocchi, Chiara, Gabriele, Martina, Andrei, Valentina, Fumagalli, Carlo, Di Mario, Carlo, Tomberli, Alessia, Olivotto, Iacopo, Perfetto, Federico, Cappelli, Francesco

“…We aimed to ascertain whether sex-related differences are relevant to clinical presentation, cardiac phenotype and all-cause mortality in different types of…”
Get full text

Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy by Ciabatti, Michele, Fumagalli, Carlo, Beltrami, Matteo, Vignini, Elisa, Martinese, Lucia, Tomberli, Alessia, Zampieri, Mattia, Bertini, Alenya, Carrassa, Gianmarco, Marchi, Alberto, Berteotti, Martina, Cappelli, Francesco, Bolognese, Leonardo, Pieroni, Maurizio, Olivotto, Iacopo

“…Despite numerous studies assessing the natural history of patients with hypertrophic cardiomyopathy (HCM), there is lack of data regarding the burden of…”
Get full text

Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy by Zampieri, Mattia, Argirò, Alessia, Marchi, Alberto, Berteotti, Martina, Targetti, Mattia, Fornaro, Alessandra, Tomberli, Alessia, Stefàno, Pierluigi, Marchionni, Niccolò, Olivotto, Iacopo

“…Purpose of review Pharmacological treatment options for hypertrophic cardiomyopathy (HCM) are currently limited and comprise non-disease specific therapies…”
Get full text

Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis by Fumagalli, Carlo, Zampieri, Mattia, Perfetto, Federico, Zocchi, Chiara, Maurizi, Niccolò, Tassetti, Luigi, Ungar, Andrea, Gabriele, Martina, Nardi, Giulia, Del Monaco, Guido, Baldini, Katia, Tomberli, Alessia, Tomberli, Benedetta, Marchionni, Niccolò, Di Mario, Carlo, Olivotto, Iacopo, Cappelli, Francesco

“…Whether diagnostic timing in transthyretin (TTR) cardiac amyloidosis (CA) predisposes patients to worse outcomes is unresolved. We aimed to describe the…”
Get full text

Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring by Fumagalli, Carlo, Bonanni, Francesca, Beltrami, Matteo, Ruggieri, Roberta, Zocchi, Chiara, Tassetti, Luigi, Maurizi, Niccolò, Berteotti, Martina, Zampieri, Mattia, Argirò, Alessia, Lovero, Fabrizio, Tomberli, Alessia, di Bari, Mauro, Marchionni, Niccolò, Pieragnoli, Paolo, Ricciardi, Giuseppe, Checchi, Luca, Cappelli, Francesco, Fumagalli, Stefano, Olivotto, Iacopo

“…Patients with hypertrophic cardiomyopathy (HCM) are at increased risk of stroke, but the incidence and factors associated with cardioembolic events in HCM…”
Get full text

686 ASSOCIATION OF PREGNANCY WITH THE NATURAL HISTORY OF WOMEN DIAGNOSED WITH HYPERTROPHIC CARDIOMYOPATHY by Fumagalli, Carlo, Zocchi, Chiara, Cappelli, Francesco, Tassetti, Luigi, Zampieri, Mattia, Maurizi, Niccolo, Tomberli, Alessia, Mecacci, Federico, Favilli, Silvia, Olivotto, Iacopo

“…Abstract Background Hypertrophic Cardiomyopathy (HCM) is the most common genetic cardiomyopathy. However, few studies have systematically investigated the…”
Get full text

Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center by Argirò, Alessia, Zampieri, Mattia, Dei, Lorenzo-Lupo, Ferrantini, Cecilia, Marchi, Alberto, Tomberli, Alessia, Baldini, Katia, Cappelli, Francesco, Favilli, Silvia, Passantino, Silvia, Zocchi, Chiara, Tassetti, Luigi, Gabriele, Martina, Maurizi, Niccolò, Marchionni, Niccolò, Coppini, Raffaele, Olivotto, Iacopo

“…We assessed the efficacy and safety of ranolazine in real-world patients with hypertrophic cardiomyopathy (HCM). Ranolazine is an anti-anginal drug that…”
Get full text

Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy by Fumagalli, Carlo, Zocchi, Chiara, Cappelli, Francesco, Celata, Anastasia, Tassetti, Luigi, Sasso, Laura, Zampieri, Mattia, Argirò, Alessia, Marchi, Alberto, Targetti, Mattia, Berteotti, Martina, Maurizi, Niccolò, Mori, Fabio, Livi, Paola, Baldini, Katia, Tomberli, Alessia, Girolami, Francesca, Favilli, Silvia, Mecacci, Federico, Olivotto, Iacopo

“…Abstract Aims Whether pregnancy is a modifier of the long-term course and outcome of women with hypertrophic cardiomyopathy (HCM) is unknown. We assessed the…”
Get full text

Red flags for the diagnosis of cardiac amyloidosis: simple suggestions to raise suspicion and achieve earlier diagnosis by Argiro’, Alessia, Zampieri, Mattia, Mazzoni, Carlotta, Catalucci, Tullio, Biondo, Beatrice, Tomberli, Alessia, Gabriele, Martina, Di Mario, Carlo, Perfetto, Federico, Cappelli, Francesco

“…Cardiac amyloidosis is an infiltrative disease characterized by extracellular deposition of insoluble amyloid fibrils in the heart leading to organ…”
Get full text

Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre by Zampieri, Mattia, Emmi, Giacomo, Beltrami, Matteo, Fumagalli, Carlo, Urban, Maria Letizia, Dei, Lorenzo-Lupo, Marchi, Alberto, Berteotti, Martina, Tomberli, Alessia, Baldini, Katia, Bettiol, Alessandra, Pradella, Silvia, Silvestri, Elena, Marchionni, Niccolò, Vaglio, Augusto, Olivotto, Iacopo, Prisco, Domenico

“…Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis. Cardiac specific involvement (CSI) is caused by coronary artery vasculitis,…”
Get full text

Sacubitril/valsartan for the treatment of non‐obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM) by Velicki, Lazar, Popovic, Dejana, Okwose, Nduka C., Preveden, Andrej, Tesic, Milorad, Tafelmeier, Maria, Charman, Sarah J., Barlocco, Fausto, MacGowan, Guy A., Seferovic, Petar M., Filipovic, Nenad, Ristic, Arsen, Olivotto, Iacopo, Maier, Lars S., Jakovljevic, Djordje G., Redzek, Aleksandar, Bjelobrk, Marija, Ilic, Aleksandra, Golubovic, Miodrag, Miljkovic, Tatjana, Maksimovic, Ruzica, Seman, Stefan, Ristic, Gorica, Markovic, Vidan, Lasica, Ratko, Brennan, Paul, Bailey, Kristian, Eggett, Christopher, Fuller, Amy, Alyahya, Alaa, Wagner, Stefan, Baessler, Andrea, Unsoeld, Bernhard, Tomberli, Alessia

“…Aim Sacubitril/valsartan treatment reduces mortality and hospitalizations in heart failure with reduced ejection fraction but has limited application in…”
Get full text

Targeted Medical Therapies for Hypertrophic Cardiomyopathy by Fumagalli, Carlo, De Gregorio, Maria Grazia, Zampieri, Mattia, Fedele, Elisa, Tomberli, Alessia, Chiriatti, Chiara, Marchi, Alberto, Olivotto, Iacopo

“…Purpose of Review The management of hypertrophic cardiomyopathy (HCM) has changed considerably over the years, although molecular therapies targeting core…”
Get full text

Red flags for the diagnosis of cardiac amyloidosis: simple suggestions to raise suspicion and achieve earlier diagnosis by Argiro’, Alessia, Zampieri, Mattia, Mazzoni, Carlotta, Catalucci, Tullio, Biondo, Beatrice, Tomberli, Alessia, Gabriele, Martina, Di Mario, Carlo, Perfetto, Federico, Cappelli, Francesco

“…Cardiac amyloidosis is an infiltrative disease characterized by extracellular deposition of insoluble amyloid fibrils in the heart leading to organ…”
Get full text

Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis by Silverii, Maria Vittoria, Argirò, Alessia, Baldasseroni, Samuele, Fumagalli, Carlo, Zampieri, Mattia, Guerrieri, Ludovica, Bartolini, Simone, Mazzoni, Carlotta, Burgisser, Costanza, Tomberli, Alessia, Di Mario, Carlo, Marchionni, Niccolò, Olivotto, Iacopo, Perfetto, Federico, Fattirolli, Francesco, Cappelli, Francesco

“…The aim of this study is to evaluate the prognostic value of cardiopulmonary testing (CPET) in a cohort of patients with transthyretin cardiac amyloidosis…”
Get full text